AGGAME

¿¹-HBc¶¨Á¿Ë®Æ½¿ÉÓÃÓÚÈ·¶¨ÂýÒҸλ¼ÕߵĸÎÔàÑ×֢ˮƽ

ÎÒ¹úÉϺ£¸´µ©´óѧÎ÷ÔÀҽԺѬȾ¿ÆLiµÈ¿ËÈÕÍê³ÉµÄÒ»ÏîÑо¿Åú×¢£¬ÔÚALTÕý³
£»ò¿¿½üÕý³£µÄÂýÐÔÒÒÐ͸ÎÑ×£¨CHB£©»¼ÕßÖУ¬Ó¦Óÿ¹-HBc¶¨Á¿Ë®Æ½¿ÉÒÔ׼ȷչÍû»¼ÕߵĸÎÔàÑ×֢ˮƽ¡£Óëµ¥¶ÀÓ¦ÓÃALTˮƽÏà±È£¬ÍŽΌ-HBc¶¨Á¿Ë®Æ½ºÍALTˮƽ½¨ÉèµÄÐÂÖ¸Êý¿ÉÒÔ×÷Ϊ¸ü׼ȷµÄÎÞ´´ÐÔÉúÎï±ê¼ÇÎÓÃÓÚÈ·¶¨CHB»¼ÕßµÄÏÔÖøÐÔ¸ÎÔàÑ×Ö¢¡£

¸ÃÏîºá¶ÏÃæÑо¿×ܹ²ÄÉÈë469Àý½ÓÊܸλî¼ìµÄCHB»¼Õߣ¬°üÀ¨½¨Ä£×é363ÀýºÍÑéÖ¤×é106Àý£¬¶Ô¿¹-HBc¶¨Á¿Ë®Æ½Óë×é֯ѧºÍѪÇå±ê¼ÇÎïµÄÏà¹ØÐÔ¾ÙÐÐϵͳÆÊÎö£¬ÆÀ¹À¿¹-HBc¶¨Á¿Ë®Æ½ÓÃÓÚÈ·¶¨CHB»¼ÕßÏÔÖøÐÔ¸ÎÔàÑ×Ö¢µÄ¼ÛÖµ¡£

ÔÚ½¨Ä£×éÖУ¬¿¹-HBc¶¨Á¿Ë®Æ½¶ÔËùÓл¼ÕßÒÔ¼°ALTˮƽÕý³
£»ò¿¿½üÕý³
£»¼Õß±£´æÖÐ-ÖضȸÎÔàÑ×Ö¢£¨¡ÝG2£©¾ù¾ßÓÐÓÅÒìµÄÕï¶Ï¼ÛÖµ£¬ÊÜÊÔÕßÊÂÇéÌØÕ÷ÇúÏßÏÂÃæ»ý£¨AUROC£©»®·ÖΪ0.768£¨95%CI£º0.721~0.810£¬P<0.001£©ºÍ0.767£¨95%CI£º0.697~0.828£¬P<0.001£©¡£ÔÚËùÓл¼ÕßÖУ¬ÍŽΌ-HBc¶¨Á¿Ë®Æ½ºÍALTˮƽ½¨ÉèµÄÐÂÖ¸Êý£¨ACÖ¸Êý£©Óëµ¥¶ÀÓ¦ÓÃALTˮƽÏà±È£¬¶ÔÈ·¶¨Ñ×Ö¢·Ö¼¶¡ÝG2µÄÕï¶ÏÐÔÄÜÏÔÖøÌá¸ß£¬AUROC»®·ÖΪ0.813£¨95%CI£º0.768~0.852£©ºÍ0.779£¨95%CI£º0.732~0.821£©¡£ÔÚÑéÖ¤×éÖУ¬ACÖ¸Êý¹ØÓÚËùÓл¼ÕßÒÔ¼°ALTÕý³
£»¼ÕßµÄÏÔÖøÐÔ¸ÎÔàÑ×Ö¢¾ùÓнϸߵÄÕï¶Ï¼ÛÖµ£¬AUROC»®·ÖΪ0.890£¨95%CI£º0.814~0.942£©ºÍ0.867£¨95%CI£º0.749~0.943£©¡£

Ô­ÎÄÁ´½Ó£ºLi J, Zhang TY, Song LW, et al. Role of Quantitative Hepatitis B Core Antibody Levels in Predicting Significant Liver Inflammation in Chronic Hepatitis B Patients with Normal or Near-normal Alanine Aminotransferase Levels. Hepatol Res. 2017 Jul 14.